The founder and owner, James DeGreef, has started, grown, and exited GenoLogics Life Sciences Software to human genome sequencing giant Illumina (NASDAQ: ILMN) and is now actively investing in new ventures.
Working with associates from his companies, business partners, and syndicate investors, James leads Haro Ventures in investment decisions and portfolio management.
A DIVERSIFIED TECH FOCUSED INVESTMENT COMPANY
WHAT WE LIKE
High potential, high growth software companies.
EARLY STAGE TECH
CRYPTO & BLOCKCHAIN
AI & MACHINE LEARNING
BC BASED COMPANIES
SOCIAL & LOCAL
OTHER TECH FUNDS
WHAT WE LOOK FOR
We examine the market size, the need for your offerings, and your positioning on the competitive landscape.
We want to see a good product-market fit, customer discovery, and to understand your product roadmap.
We listen for expertise, determination, and drive. We want a team who is ready to take over the world.
We need a measure for early customers to understand your projections and viability of your business.
Some things can't be said in words or recorded in a due diligence list, but simply stands out from the crowd.
If you have an investment opportunity that you believe fits Haro's mandate, please email at: